Health
New staging system can inform treatment decisions for non-metastatic prostate cancer – News-Medical.Net
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.
Although it is one of the most common cancers worldwide, prostate cancer remains one of the few major cancers for which the familiar, numerical staging system -; ranging from stage 1 to stage 4 -; has not…
-
General12 hours agoNew US tariffs on semiconductors coming ‘over the next week’, Donald Trump says
-
Noosa News12 hours agoAustralian Idol 2025 winner draws crowd for Noosa pop up show
-
Noosa News21 hours agoWoman dies, 10 rushed to hospital after Bald Hills collision
-
Noosa News21 hours agoWoman killed, 10 injured as van slams into idling cars in three-vehicle smash in Brisbane’s north